Each year, the ARUP Institute for Clinical and Experimental Pathology® presents at more than 200 conferences, workshops, annual meetings, and symposiums for several national and international organizations. Recent posters and presentations are listed below.
Seegene Webinar Series
Salt Lake City, UT, February 15, 2023
Mathison BA, Butler-Wu S, Bradbury RS. Diagnostic parasitology—As-is and to-be, a roundtable on the future.
The Society for Maternal Fetal Medicine Annual Pregnancy Meeting (SMFM)
San Francisco, CA, February 6-11, 2023
Moyle KA, Peterson LK, Guerra MM, Kim M, Allshouse AA, Benson AE, Salmon JE, Branch DW. Anti-β2 glycoprotein-1 domain 1 antiphospholipid antibodies as a marker for adverse pregnancy outcomes.
American Society of Hematology (ASH)
New Orleans, LA, December 10–13, 2022
Kanack A, Leger R, Saadalla A, Heikal NM, Chen D, Garcia D, Pruthi RK, Padmanabhan A. Autoimmune HIT, a potential diagnostic artifact due to remnant heparin in HIT samples, is not associated with more severe outcomes.
Saadalla A, Chen D, Pruthi R, Heikal N, Snyder M, Ashrani A, Seheult J. The lupus anticoagulant titer is associated with elevated antiphosphatidyl-serine/prothrombin antibody levels.
Clinical Diagnostics and Research
Virtual, November 9, 2022
Pandya V. Tumor markers as cancer screening and surveillance tools.
Annual Current Issues in Anatomic Pathology
San Francisco, CA, November 4, 2022
Ohgami R. Practical issues in molecular testing of lymphomas.
Association for Molecular Pathology (AMP)
Phoenix, AZ, November 1–5, 2022
Szankasi P, Kellogg A, Bolia A, Paxton C, O'Fallon B, Rindler P, Close D, Li P, Patel JL—Poster
Szankasi P, Kellogg A, Bolia A, Paxton C, O'Fallon B, Rindler P, Close D, Li P, Patel JL. Performance comparison of a capture-based oncology NGS panel with SNP array and FISH for the detection of genome-wide copy number variants and copy number neutral loss of heterozygosity.
American Society of Human Genetics (ASHG)
Los Angeles, CA, October 25–29, 2022
O'Fallon BD, Durtschi J, Bolia A, Yang L, Noble K, Fredrickson E, Coleman J, Best H—Poster
O'Fallon BD, Durtschi J, Bolia A, Yang L, Noble K, Fredrickson E, Coleman J, Best H. NGS variant detection as a sequence-to-sequence modeling problem.
American Society for Histocompatibility and Immunogenetics (ASHI)
Las Vegas, NV, October 24–28, 2022
Jain D, Profaizer T, Lazar-Molnar E—Poster
Jain D, Ellinger L, Profaizer T, Lazar-Molnar E. Assessment of clinical utility of next generation sequencing assay for chimerism analysis.
International Clinical Cytometry Society (ICCS)
Montreal, Quebec Canada, October 21–25, 2022
Ng DP, Loghavi S. Technical and diagnostic considerations in eosinophils, mast cells, basophils and PDCs by flow cytometry: part 1.
Ng DP. A review of AI in clinical flow cytometry.
Lin L. Experience with the BD FACSDuetTM sample preparation system in a high-volume reference laboratory.
Ventura MF, Andreasen J, Delgado J, Lin L—Poster
Ventura MF, Andreasen J, Delgado J, Lin L. Experience with the BD FACSDuet sample preparation system in a high-volume reference laboratory.
Washington, DC, October 19–23, 2022
Mathison BA. AI for the enhanced detection of intestinal protozoans.
Australasian Association for Clinical Biochemistry Annual Scientific Conference
Perth, Australia, October 18–20, 2022
Jackson BR. Artificial intelligence in the clinical pathology laboratory.
Las Vegas, NV, October 16–18, 2022
Liew M, Rowe L, Moore K, Brooks M, Aston E, O Brien KR, Longhurst M, Wilcock D, Kenney J, Priest M, Rets AR, Miles R—Poster
Liew M, Rowe L, Moore K, Brooks M, Aston E, O Brien KR, Longhurst M, Wilcock D, Kenney J, Priest M, Rets AR, Miles R. Validation of Rapid MYC and BCL6 break apart digital fluorescence in situ hybridization assays.
College of American Pathologists (CAP)
New Orleans, LA, October 8–11, 2022
Wilcock DM, Moore K, Rowe LR, Gulbahce EH, Sirohi D—Poster
Wilcock DM, Moore K, Rowe LR, Gulbahce EH, Sirohi D. Quantitative image analysis of HER2 fluorescence in-situ hybridization: need for standardization.
Luo MX, Ng DP, Rets A, Menon MP—Poster
Luo MX, Ng DP, Rets A, Menon MP. Clinicopathologic characteristics of CD5+ and/or CD10+ MYD88 mutated lymphoplasmacytic lymphoma.
HHT International Scientific Conference
Estoril, Cascais, Portugal, September 29–October 2, 2022
DeMille D, McDonald J, Bayrak-Toydemir P—Presentation
DeMille D, McDonald J, Bernabéu C, Dupuis-Girod S, Ganguly A, Giraud S, Ichikawa S, Jessen J, Jovine L, Kasthuri RS, Olivieri C, Ploos van Amstel HK, Racher H, Shovlin CL, Bayrak-Toydemir P. ClinGen HHT variant curation expert panel's modified variant interpretation and classification guideline.
Pan American Society for Clinical Virology (PASCV)
Chicago, IL, September 22–23, 2022
Tardif KD, Shakir SM—Poster
Tardif KD, Shakir SM. Development and validation of genital ulcer disease PCR panel.
Southeastern Regional Genetics Conference
Charleston, SC, September 8–9, 2022
Quigley, DI. Cytogenetic testing in B-cell ALL.
American Society for Clinical Pathology (ASCP)
Chicago, IL, September 7–9, 2022
Miles RR. Extra-thymic immature t-cells: indolent proliferation or lymphoblastic lymphoma?
Moser KA. Resident review series: coagulation.
International Congress on Parasitology (ICOPA)
Copenhagen, Denmark, August 21–26, 2022
Mathison BA. Systematic identification of parasitic nematodes of humans in histopathology specimens.
Association of Medical Laboratory Immunologists (AMLI)
Salt Lake City, UT, August 12–15, 2022
Smith TL, Haven TR, Zuromski LM, Peterson LK—Poster
Smith TL, Haven TR, Zuromski LM, Peterson LK. Detection of myelin oligodendrocyte glycoprotein antibodies.
Ravkov EV, Joshi H, Andreasen J, Delgado JC, Lin L—Poster
Ravkov EV, Joshi H, Andreasen J, Delgado JC, Lin L. Leukocyte adhesion deficiency (LAD) type 2: establishing specificity and sensitivity in disease phenotype simulated cells.
Martins TB, Hill HR, Peterson LK—Poster
Martins TB, Hill HR, Peterson LK. Reevaluating pneumococcal polysaccharide vaccine response in assessing immunocompetence.
Braun K, Peterson LK, Snyder MR, Lebiedz-Odrobina D, Tebo AE. Determination of Ro52 and Ro60 antibodies in patients at-risk for connective tissue disease: a comparative study.
Moyle KA, Peterson LK, Guerra MM, Allshouse AA, Benson AE, Salmon JE, Branch DW. Anti-domain 1 antiphospholipid antibodies as a marker for adverse pregnancy outcomes in SLE and APS.
Tebo AE, Peterson LK, Jaskowski TD, Knapp D, Craig C—Poster
Tebo AE, Peterson LK, Jaskowski TD, Sales S, Knapp D, Craig C, Snyder MR, Lebiedz-Odrobina D. U1RNP antibody testing in connective tissue disease evaluation: analyte-dependent performance characteristics and significance of appropriate nomenclature.